2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Legacy Housing appointed co-founder Kenneth E. Shipley as Chairman of the Board and Chief Executive Officer effective August 13, 2026, replacing him as interim CEO, a role he had held since October 10, 2025. Shipley will receive a salary of $50,000 per year and has no written employment agreement or set term, and the filing discloses ongoing home sales to retailers owned by Shipley-linked significant shareholders.
Kenneth E. Shipley, age 67, appointed Chairman and CEO effective August 13, 2026; he had been interim CEO since October 10, 2025
Salary set at $50,000 per year; no written employment agreement and no set term of employment
Home sales to related retailers Bell Mobile Homes and Shipley Bros./Crazy Red's were $4.8 million and $2.1 million for 2025
Curtis D. Hodgson retired as Executive Chairman and director effective July 21, 2026
Huntsman filed supplemental disclosures to its joint proxy statement/prospectus for the proposed merger with Olin, made voluntarily to address lawsuits and demand letters alleging omissions. Huntsman and Olin say the claims are without merit, and the Huntsman stockholder vote is scheduled for August 25, 2026.
Huntsman stockholder and Olin shareholder special meetings are both set for August 25, 2026.
Two New York complaints by Huntsman stockholders were filed July 30, 2026, seeking to enjoin the vote or the merger.
A Missouri complaint by Olin shareholders against Olin, its board and Huntsman was filed as of August 11, 2026.
Supplements add Lazard and Citi analysis details, including net debt of approximately $1,908 million for Huntsman as of March 31, 2026.
CapsoVision, Inc. entered into a Controlled Equity Offering sales agreement with Cantor Fitzgerald & Co. on August 13, 2026, allowing it to sell up to $100 million of common stock from time to time at its discretion. The filing discloses a legal opinion and registration details but no sales have been reported, and the filing does not state the company's use of proceeds or any financial results.
Sales agreement dated August 13, 2026 with Cantor Fitzgerald & Co. as sales agent or principal
Aggregate offering price of up to $100,000,000 of common stock, par value $0.001 per share
Shares sold under Form S-3 registration statement (File No. 333-298315) filed August 13, 2026
Legal opinion from O'Melveny & Myers LLP dated August 13, 2026, filed as Exhibit 5.1
First Industrial Realty Trust filed an amendment to an earlier 8-K to disclose committee assignments for director Frank E. Schmitz, who joined the Board effective June 1, 2026. On August 13, 2026, the Board appointed him to its Nominating/Corporate Governance Committee and Compensation Committee. The filing is administrative and does not describe a change in financial results or strategy.
Frank E. Schmitz was elected to the Board effective June 1, 2026, when the Board size increased from six to seven members.
On August 13, 2026, the Board appointed Mr. Schmitz to the Nominating/Corporate Governance Committee and the Compensation Committee.
The amendment was filed to provide committee assignment details omitted from the original 8-K.
Coherus Oncology declared a special dividend of contingent value rights (CVRs) to shareholders of record on September 30, 2026, with distribution on October 7, 2026. CVR holders may receive future cash payments only if the company sells or licenses its remaining biosimilar assets, and any payments depend on net cash proceeds actually received during a term ending October 7, 2028.
One CVR per common share held at 5:00 p.m. Eastern Time on September 30, 2026 (Record Date); distribution date October 7, 2026
Payments depend on net cash proceeds from the Legacy BioSim Assets, which include patents, royalties under an existing license, cell lines and related materials; no minimum payment is guaranteed
CVRs expire October 7, 2028 and are non-transferable and not listed; a Loan and Security Agreement dated August 12, 2026 with Innovatus Life Sciences Lending Fund I, L.P. restricts disposition of the assets and CVR payments
Private Bancorp of America, Inc., the holding company for CalPrivate Bank, announced on August 17, 2026 that Andra Frazier has been appointed Executive Vice President and Chief Credit Officer of the Bank. The filing says Ms. Frazier brings decades of banking experience at regional and community banks, and the company describes the role as supporting strategic growth and credit risk management. The filing does not discuss compensation or the financial effect of the hire.
Andra Frazier appointed Executive Vice President and Chief Credit Officer of CalPrivate Bank, announced August 17, 2026
Company reported $2.71 billion in assets, $2.13 billion in loans and $2.38 billion in deposits as of June 30, 2026
For the quarter ended June 30, 2026, net income was $13.1 million and diluted earnings per share were $2.27
Nasdaq notified Helix Acquisition Corp. III on August 14, 2026 that it does not meet the 300 Total Holders requirement for continued listing on the Nasdaq Global Market. The company says the notice is a deficiency notification, not an imminent delisting, and its Class A shares will continue to trade as HLXC.
Nasdaq notice received August 14, 2026 under Listing Rule 5452(a)(2)(A), requiring at least 300 Total Holders
Company has 45 calendar days to submit a plan to regain compliance
If accepted, Nasdaq may grant an extension of up to 180 calendar days from the notice date; otherwise the company may appeal to a Nasdaq Hearings Panel
Covenant Logistics Group's board declared a quarterly cash dividend of $0.07 per share on Class A and Class B common stock, under a program the board previously approved. Holders of record on September 4, 2026 are expected to receive the payment on September 25, 2026. The filing contains no financial results, and the dividend is a routine declaration under an existing program.
Dividend amount: $0.07 per share on Class A and Class B common stock
Record date: September 4, 2026
Expected payment date: September 25, 2026
Declared August 13, 2026 under a previously approved quarterly dividend program
WidePoint Corporation (WYY) furnished its financial results for the six months and quarter ended June 30, 2026, in a press release and earnings call transcript dated August 13, 2026. The 8-K filing itself does not state revenue, profit, or guidance figures, so shareholders must review Exhibits 99.1 and 99.2 for the results.
Results cover the six months and quarter ended June 30, 2026.
Earnings call and press release were both on August 13, 2026.
Exhibit 99.1 is the earnings call transcript; Exhibit 99.2 is the earnings press release.
CEO Jin Kang signed the filing on August 17, 2026.
Kulicke & Soffa named Dr. Raj Talluri as President and Chief Executive Officer effective September 1, 2026, and elected him to its Board effective August 17, 2026. Interim CEO Lester Wong will remain Executive Vice President and Chief Financial Officer. The filing also sets out Talluri's pay, including a $750,000 base salary and a one-time new-hire equity award with a target value of $14.0 million.
Talluri becomes President and CEO on September 1, 2026, and joined the Board on August 17, 2026.
Talluri was President and CEO of Enovix Corporation from January 2023; he was at Micron Technology from March 2018 to December 2022.
Offer letter terms include a $750,000 base salary, a target bonus of 110% of base salary, and a $6.0 million target annual equity award.
Lester Wong, interim CEO, continues as Executive Vice President and Chief Financial Officer.
On August 12, 2026, Singularity Future Technology Ltd. agreed to sell 21,520,803 shares of common stock at $1.394 per share to non-U.S. investors, for an aggregate purchase price of approximately $30 million. Closing depends on conditions in the agreement, including shareholder approval, and the sale would add to the number of shares outstanding.
21,520,803 shares of common stock to be sold at $1.394 per share
Aggregate purchase price of approximately $30 million
Agreement dated August 12, 2026, sold to certain non-U.S. persons under Regulation S
Closing requires receipt of the Company's shareholders' approval of the offering
Nocera's Board concluded on August 14, 2026 that its previously issued 2024 and 2025 annual financial statements and its 2025 quarterly statements should no longer be relied upon because of errors. The company is filing Amendment No. 2 to its 2025 Form 10-K with restated results, which lowers 2024 goodwill and reduces 2025 net sales, while the company has previously disclosed material weaknesses in internal controls.
Board concluded on August 14, 2026 that 2024 and 2025 annual statements and Q1-Q3 2025 interim statements should no longer be relied upon.
2024 goodwill reduced by about $1,351,703, from $2,077,728 to $726,025; accumulated losses at December 31, 2024 increased by about $2,096,572.
2025 net sales reduced by about $2,597,349, offset by lower cost of sales; total 2025 net loss unchanged.
Company cites material weaknesses in internal controls and says remedial measures may not prevent future misstatements.
At a special meeting on August 17, 2026, LiveRamp stockholders adopted the May 16, 2026 Agreement and Plan of Merger under which Merger Sub will merge into LiveRamp, making it a wholly owned subsidiary of MMS USA Holdings. Stockholders also elected three directors, approved a 2,500,000-share increase to the 2005 Equity Compensation Plan, and did not approve merger-related executive compensation in an advisory vote.
Merger Agreement adopted with 51,578,202 votes for, 60,073 against and 53,553 abstentions, out of 60,786,315 shares outstanding on the June 18, 2026 record date.
Merger-related compensation of named executive officers was not approved in an advisory vote: 44,262,875 against and 7,304,002 for.
Timothy R. Cadogan, Vivian Chow and Scott E. Howe were elected to the Board for terms expiring at the 2029 Annual Meeting.
The 2005 Equity Compensation Plan was amended to add 2,500,000 shares, with the plan text filed as Exhibit 10.1.
Park Aerospace appointed Constantine Petropoulos as Senior Vice President and Chief Financial Officer effective August 12, 2026, according to the filing. He previously served as Senior Vice President and Chief Legal and Capital Markets Officer, and the company raised his annual base salary to $425,000 and granted him an option on 25,000 shares.
Constantine Petropoulos, age 48, appointed SVP and Chief Financial Officer effective August 12, 2026
Prior role: SVP and Chief Legal and Capital Markets Officer since January 2026
Annual base salary increased from $357,000 to $425,000, effective August 12, 2026
Stock option for 25,000 shares at $37.47 per share, vesting 25% annually over four years, expiring ten years from grant
Flexsteel reported fourth quarter and fiscal 2026 results on August 17, 2026. Q4 net sales rose 0.7% to $115.4 million and GAAP diluted EPS was $2.58 versus $1.89, helped by a $9.0 million tariff refund that the company excludes from its adjusted figures. Adjusted diluted EPS fell to $1.33 from $1.40, and the company guided first-quarter fiscal 2027 sales of $111 million to $115 million.
Q4 net sales were $115.4 million, up from $114.6 million; the CEO called it the eleventh consecutive quarter of year-over-year growth.
Q4 GAAP diluted EPS was $2.58 versus $1.89; adjusted diluted EPS was $1.33 versus $1.40.
Fiscal 2026 net sales rose 4.1% to $459.2 million; GAAP diluted EPS was $6.07 versus $3.55.
First-quarter fiscal 2027 outlook: sales growth of 1% to 4%, GAAP operating margin of 6.5% to 7%; conference call on August 18, 2026 at 8:00 a.m. Central Time.
Limoneira subsidiary Windfall Investors agreed on August 15, 2026 to sell five Paso Robles, California vineyard properties of about 724 acres to Paul Rusnak for $15 million, following a public auction. The company also expects an additional impairment charge of about $4.1 million, bringing the total impairment to about $13.4 million, which the company links to the sale and to a previously terminated sale.
Purchase price is $15 million; buyer must post a 12% nonrefundable earnest money deposit
Closing is scheduled no later than September 14, 2026 (the press release says September 15); the deal is not conditioned on financing
Additional impairment of about $4.1 million expected in Q4 fiscal 2026, on top of about $9.3 million previously estimated for Q2, for about $13.4 million total
Seller keeps the 2026 harvest and access to farm through November 30, 2026; CEO Harold Edwards said proceeds will reduce debt and fund avocado acreage expansion
Vuzix reported second-quarter 2026 results for the three months ended June 30, 2026, in a press release dated August 13, 2026. Total sales fell 14% to $1.1 million from $1.3 million, while the net loss was $7.7 million, or $0.09 per share, compared with $0.10 per share a year earlier. The company had $17.3 million in cash and no debt at June 30, 2026, but operating cash use rose to $6.6 million from $4.8 million.
Total sales were $1.1 million versus $1.3 million, a 14% decline; product sales fell 15% to $0.9 million.
Net loss was $7.7 million, or $0.09 per share, compared with a loss of $7.7 million, or $0.10 per share, in the second quarter of 2025.
Research and development expense rose 20% to $3.1 million, while the gross loss narrowed to $0.6 million from $0.8 million.
Net cash used in operating activities was $6.6 million, up from $4.8 million; cash totaled $17.3 million with no current or long-term debt.
UGI Utilities, a wholly owned subsidiary of UGI Corporation, completed a $125 million private placement of 5.45% senior notes on August 11, 2026, with maturity on August 15, 2031. Proceeds will primarily refinance indebtedness and fund general corporate purposes, and the filing reports no earnings or guidance figures.
Principal amount: $125 million of 5.45% senior notes, funded August 11, 2026 and priced July 23, 2026
Maturity date August 15, 2031; interest paid semiannually on February 15 and August 15
Notes are unsecured and rank equally with UGI Utilities' existing and future unsecured debt; the agreement limits total debt to 0.65 to 1.00 of total capitalization
Holders can require prepayment if UGI Utilities ceases to be majority owned by UGI Corporation
NNN REIT said Christina Chiu and Charles “Chaz” D. Mueller, Jr. will join its Board effective October 1, 2026, as part of staged succession planning. Director Betsy D. Holden plans to retire from the Board on February 19, 2027, and the Board expects both new directors to serve on the Audit Committee.
Chiu and Mueller join the Board effective October 1, 2026.
Holden's planned retirement from the Board is effective February 19, 2027.
The Board expects to appoint both Chiu and Mueller to the Audit Committee.
Chiu is President of Empire State Realty Trust; Mueller sits on the Board of Trustees of Vivmark Residential.
ResMed dismissed KPMG as its independent auditor on August 13, 2026, and appointed PricewaterhouseCoopers for the fiscal year ending June 30, 2027, subject to PwC's client acceptance procedures. The filing also reports that director Ron Taylor will not stand for reelection and will retire at the November 18, 2026 annual meeting, with Carol Burt named lead director effective November 15, 2026.
KPMG's reports on the fiscal 2026 and 2025 financial statements contained no adverse opinion, disclaimer, or qualification, and the filing reports no disagreements or reportable events.
PwC appointed on August 13, 2026, following a competitive review by the Audit Committee, subject to completion of its standard client acceptance procedures.
Ron Taylor, a director since 2005 and lead director since 2013, is retiring at the 2026 Annual Meeting on November 18, 2026, and his retirement is not due to any disagreement with the company.
Carol Burt, a Board member since 2013 who chairs the Nominating and Governance Committee, becomes lead director on November 15, 2026.
DocGo signed a merger agreement on August 16, 2026 to acquire virtual care provider Hicuity Health, with Hicuity becoming a wholly owned subsidiary, subject to closing conditions. The same day it reported second-quarter 2026 results showing lower revenue, a wider net loss, and a lower full-year adjusted EBITDA outlook, which weigh on shareholders.
Q2 2026 revenue was $73.4 million, down from $80.4 million a year earlier; migrant-related programs contributed $18.8 million in Q2 2025 and none in Q2 2026.
Q2 2026 net loss was $18.0 million, versus $13.3 million in Q2 2025; adjusted EBITDA was ($6.3) million, versus ($6.1) million.
Full-year 2026 adjusted EBITDA guidance is now ($17)-($22) million, down from prior guidance of ($5)-($10) million; revenue guidance was narrowed to $305-$310 million from $300-$315 million.
Hicuity's Series F preferred holder would receive the entire merger consideration: 2.0% of DocGo shares plus up to 3.5% in earnout shares; Ambulnz will assume about $52 million of Hicuity debt, and Perceptive Credit Holdings IV has committe
MasTec, Inc. completed a public offering of $650.0 million in 5.850% senior unsecured notes due September 30, 2036, issued August 17, 2026 under an existing 2009 indenture. The notes add $650.0 million of long-term debt, rank equally with the company's other senior unsecured debt, and are not guaranteed by subsidiaries.
Principal amount: $650.0 million of 5.850% senior unsecured notes due 2036
Interest payable March 30 and September 30 each year, starting March 30, 2027
Notes are not guaranteed by subsidiaries and are structurally subordinated to their obligations, including trade payables
Company may redeem the notes in whole or in part at prices set in the indenture
Fabrinet reported record fourth-quarter fiscal 2026 revenue of $1,315.8 million, up from $909.7 million a year earlier, and GAAP diluted EPS of $3.83 versus $2.42. The company guided first-quarter fiscal 2027 revenue to $1.375 billion to $1.425 billion and non-GAAP diluted EPS to $4.10 to $4.25, and its Thai subsidiary took a term loan of about $75.0 million guaranteed by Fabrinet.
Q4 fiscal 2026 revenue of $1,315.8 million, up from $909.7 million; GAAP net income of $139.3 million versus $87.2 million
Fiscal 2027 first-quarter guidance: revenue of $1.375 billion to $1.425 billion; non-GAAP EPS of $4.10 to $4.25
On August 17, 2026, Fabrinet Co., Ltd. borrowed a THB 2.50 billion (about $75.0 million) term loan from Bank of Ayudhya, guaranteed by Fabrinet, to support capital expenditures
On August 11, 2026, the compensation committee raised CEO Seamus Grady's base salary to $1,500,000 and set his fiscal 2027 target bonus at $2,625,000
AdvanSix completed a refinancing of its senior secured credit facilities on August 14, 2026, replacing its existing agreement with a new $275 million revolving facility and a $150 million term loan, both maturing August 14, 2031. The company repaid the prior facility in full, and the new borrowings are secured by substantially all of its tangible and intangible assets.
New revolving credit facility of $275 million and term loan of $150 million, both maturing August 14, 2031, with Citizens Bank, N.A. as administrative agent.
At closing, AdvanSix had borrowed $145 million under the revolver and $150 million under the term loan, with about $17 million of cash on hand.
Existing facility with Truist Bank as administrative agent was paid off in full and terminated on August 14, 2026.
Covenants include a minimum Consolidated Interest Coverage Ratio of 3.00 to 1.00 and a maximum Consolidated Leverage Ratio of 3.75 to 1.00, with limits on dividends and share repurchases.
CVS Health appointed Teresa Heitsenrether, Executive Vice President and Chief Data & Analytics Officer at JPMorgan Chase, to its Board of Directors, effective November 18, 2026. Larry Robbins resigned from the Board effective August 13, 2026, and the company said his resignation was not due to any disagreement with the company. The filing reports no financial results, so the change is a board composition update rather than a change to company performance.
Teresa Heitsenrether joins the Board effective November 18, 2026, and was determined to be independent under NYSE rules.
Larry Robbins resigned from the Board effective August 13, 2026, after serving since 2024.
Heitsenrether's director compensation will match other non-employee directors, prorated for her start date.
CEO David Joyner said Heitsenrether brings experience in data, analytics and technology.
Kaiser Aluminum said Fred Stephan, 61, a former Chief Operating Officer of Amcor's flexible packaging unit, will become CEO and President on November 1, 2026, succeeding Keith A. Harvey, who will become Executive Chairman. The Board will grow from nine to ten directors when Stephan joins, and the company amended its Key Employee Severance Plan, which covers Stephan's severance terms.
Stephan's offer letter sets a base salary of $1,150,000, a short-term cash incentive target of $1,440,000 and a long-term incentive target of $4,430,000 beginning in 2027.
Stephan receives a sign-on restricted stock unit grant with a target value of $2,000,000 on the November 1, 2026 effective date.
Harvey, CEO since July 31, 2020, will serve as a special advisor to Stephan through October 31, 2027.
The Board will increase from nine to ten directors on the effective date.
BigBear.ai's board elected Ret. Lt. Gen. Sean Gainey as a director effective August 13, 2026, and appointed him to the Nominating and Corporate Governance Committee. The filing describes his prior Army and Department of Defense leadership roles and his director compensation, which includes a prorated annual restricted stock unit award.
Board elected Ret. Lt. Gen. Sean Gainey on August 13, 2026, and named him to the Nominating and Corporate Governance Committee.
Gainey led Army and joint force Space and Missile Defense from January 2024 through April 2026.
He will receive director compensation under the company's policy, including a prorated annual restricted stock unit award, and has signed the standard indemnification agreement.
AT&T closed on August 17, 2026 the sale of €1.2 billion of Euro floating rate notes and $1.1 billion of USD floating rate notes, both due 2028. The filing is a routine administrative update that files underwriting agreements, note forms and legal opinions for incorporation into its existing S-3 registration statement, and it gives no information on earnings or guidance.
Euro Notes: €1.2 billion aggregate principal, underwritten by Deutsche Bank AG, London Branch under an agreement dated August 7, 2026
USD Notes: $1.1 billion aggregate principal, underwritten by BNP Paribas Securities Corp. under an agreement dated August 10, 2026
Notes issued under a May 15, 2013 indenture with The Bank of New York Mellon Trust Company, N.A., as trustee, and registered on Form S-3 (No. 333-285413)
Maze Therapeutics named two new non-employee directors, Paula Johnson and Sophie Kornowski, effective August 13, 2026, and announced the appointments in a press release that day. The Board also reassigned two existing directors to different classes so that each class has roughly one-third of the Board, as its certificate of incorporation contemplates.
Paula A. Johnson, M.D., M.P.H., joined as a Class III director with a term expiring at the 2028 annual meeting and was added to the nominating and corporate governance committee.
Sophie Kornowski, Pharm.D., joined as a Class I director with a term expiring at the 2029 annual meeting and was added to the audit and compensation committees.
Each new director receives a pro rata share of the $40,000 annual cash retainer and an option to purchase 36,000 shares of common stock, vesting monthly from the appointment date.
Nancy C. Andrews and Hervé Hoppenot resigned and were immediately reappointed to Class II and Class III, respectively.
Phoenix Energy One, LLC and its subsidiary Phoenix Operating LLC entered into Amendment No. 10 to their senior secured credit agreement on August 12, 2026. The $75 million in Amendment No. 7 discretionary delayed draw term loan commitments was fully drawn on that date, and the discretionary amount available from time to time was reduced from $225 million to $150 million. The loans will fund oil and gas development, and the filing adds debt to the company's obligations.
$75 million in Amendment No. 7 discretionary delayed draw term loan commitments was fully drawn as of August 12, 2026, subject to 3.00% original issue discount
Discretionary availability under Amendment No. 7 reduced from $225 million to $150 million
Proceeds will finance oil and gas development under the approved plan of development
Repayment premium changed to a MOIC of 1.15 for certain loan groups and 1.18 for other loan groups
TON Strategy Company increased its board from five to six members on August 17, 2026, and appointed Oscar Suarez to the new seat effective that day. Suarez will also replace Nicolas Cary as chair of the audit committee, so shareholders will see a new person overseeing the company's audit function.
Board expanded from five to six members; Oscar Suarez appointed effective August 17, 2026
Suarez succeeds Nicolas Cary as audit committee chairman
Suarez previously held roles at KPMG (1989 to 2004, partner in 1995) and Ernst & Young (2004 to 2021); he currently chairs the audit committee of Amerant Bancorp Inc.
He will receive non-employee director compensation under the policy described in the April 30, 2026 proxy statement and will sign the company's standard indemnification agreement
Cocrystal Pharma announced that Carol Brosgart, MD has joined its Board of Directors, effective August 12, 2026. The company said her antiviral drug development experience will support its CDI-988 norovirus program and broader antiviral pipeline.
Board appointment effective August 12, 2026; announced August 17, 2026
Dr. Brosgart spent more than a decade at Gilead Sciences, where she worked on Viread and Hepsera
Chairman Roger Kornberg said her insights will help advance CDI-988 for norovirus
Sonida Senior Living filed unaudited pro forma combined financial statements as Exhibit 99.1 to an 8-K. They show results for the year ended December 31, 2025 and the six months ended June 30, 2026 as if its March 11, 2026 acquisition of CNL Healthcare Properties had occurred on January 1, 2025. The company states the figures are illustrative only and do not indicate actual or future results.
Pro forma net loss attributable to common shareholders: $82.3 million ($1.76 per share) for the six months ended June 30, 2026, and $168.4 million ($3.61 per share) for 2025
Pro forma total revenues: $410.3 million for the six months ended June 30, 2026, and $774.3 million for 2025
The pro forma bridge facility assumes $270 million outstanding for the full periods; later refinancing from March 11 to August 7, 2026 is not reflected
The filing was voluntary and supports incorporation by reference into the company's registration statements
Aon's Executive Vice President and Chief Financial Officer, Edmund Reese, moved out of the CFO role effective August 17, 2026, and will serve as a senior advisor through August 16, 2027. Nadin Virani, 49, became interim Chief Financial Officer on the same date, and the filing does not name a permanent successor.
Edmund Reese's CFO role ended August 17, 2026; he is a senior advisor to the company through August 16, 2027.
Nadin Virani, 49, is interim CFO effective August 17, 2026. He had been Global Head of Corporate Planning and Analytics since January 2025.
Virani's base salary rises by $50,000 per month during his interim term, and he is eligible for a cash bonus equal to the extra salary earned.
The transition is covered by a Letter Agreement with Reese dated August 17, 2026, filed as Exhibit 10.1.
Permianville Royalty Trust announced a cash distribution of $0.027000 per unit, payable September 15, 2026, to unitholders of record on August 31, 2026. Oil cash receipts rose $0.1 million to $3.3 million, while natural gas receipts fell $0.4 million to $1.1 million, and the Sponsor kept a $2.0 million reserve for future development expenses, which could be released later if unspent.
Distribution of $0.027000 per unit, payable September 15, 2026, record date August 31, 2026
Oil cash receipts $3.3 million, up $0.1 million from the prior month, at $95.23 per barrel
Natural gas cash receipts $1.1 million, down $0.4 million from the prior month, at $2.37 per Mcf
Sponsor COERT Holdings 1 LLC maintains a $2.0 million reserve for approved future development expenses
In connection with the closing of the Mergers on August 17, 2026, ERP Operating Partnership assumed AvalonBay's obligations under a $2.5 billion revolving credit facility and a $550 million term loan facility, and also assumed Merger Sub's obligations under multiple series of unsecured notes. The filing does not describe the Mergers' terms or their financial effect, so shareholders can see the debt structure but not the deal's economics here.
On August 17, 2026, ERP Operating Partnership became the new borrower under the $2.5 billion revolver and $550 million term loan, which were previously AvalonBay's facilities.
As of August 17, 2026, $1.205 billion was borrowed under the revolver and the full $550 million was outstanding under the term loan.
The revolver matures April 3, 2030 and the term loan matures April 3, 2029; the current spreads are 72.5 and 80 basis points per annum.
Supplemental indentures dated August 17, 2026 transfer unsecured notes issued under 1998, 2018 and 2024 indentures, with individual series ranging from $300 million to $700 million in principal.
Neuronetics said Nir Naor, its Executive Vice President and Chief Financial Officer, was appointed principal financial and accounting officer on August 12, 2026, ending Francis X. Brown III's interim role effective August 11, 2026. Brown will continue as a consultant, and the filing states no disagreement with the company led to the change.
Nir Naor appointed principal financial and accounting officer by the Board on August 12, 2026
Naor's title is now Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer
Francis X. Brown III's interim role ended August 11, 2026; he will continue as a consultant
Naor received no new compensation for the appointment or title change
Empire Petroleum reported second-quarter 2026 product revenue of $11.1 million, up from $8.7 million a year earlier, and a net loss of $1.9 million, or $0.05 per diluted share, compared with a $5.1 million loss, or $0.15 per share, in Q2 2025. The filing attributes the higher revenue mainly to higher realized oil pricing, partly offset by lower production, and the company gave qualitative operating updates without a numeric forecast.
Total product revenue was $11.1 million in Q2 2026, up from $8.7 million in Q2 2025 and $7.7 million in Q1 2026.
Net loss was $1.9 million, or $0.05 per diluted share, versus a $5.1 million loss, or $0.15 per share, in Q2 2025.
Adjusted EBITDA was $0.4 million, compared with negative $1.2 million in Q2 2025.
Cash on hand was $3.1 million at June 30, 2026; no shares had been sold under a $7.5 million at-the-market sales agreement with Roth Capital Partners.
Teradata's board approved a form of indemnification agreement on August 12, 2026, and entered into it with each director and executive officer. The agreements commit the company to indemnify and advance expenses to each covered person to the fullest extent Delaware law permits, and to cover them under its directors' and officers' insurance policies. The filing is administrative and does not describe any financial figures.
Board approved the form of Indemnification Agreement on August 12, 2026
Agreements cover each Teradata director and executive officer
Teradata will indemnify and advance expenses to the fullest extent permitted under Delaware law
Full terms are in Exhibit 10.1, filed with the 8-K
Rocket Companies expanded its Board of Directors from nine to ten members and appointed Sarah Watterson as a Class III director, effective August 17, 2026. The filing says she is independent and will receive a $75,000 annual cash retainer and a $215,000 initial RSU grant, which vests after one year.
Sarah Watterson appointed Class III director effective August 17, 2026, with a term expiring at the 2029 annual meeting
Board expanded from nine to ten directors to fill the newly created seat
Compensation: $75,000 annual cash retainer, prorated, plus RSUs with an initial grant value of $215,000 vesting after one year
Watterson previously held senior roles at Brightline West, Fortress Investment Group and Goldman Sachs, per the filing
Fastly amended its credit agreement on August 17, 2026, increasing its senior secured revolving facility from $60.0 million to $100.0 million and extending the scheduled maturity to August 17, 2029. The amendment also lowers borrowing rates by 0.25% and changes the commitment fee structure, with maturity terms tied to Net Liquidity tests linked to its 7.75% convertible notes due 2028.
Revolving commitments increased from $60.0 million to $100.0 million.
Scheduled Revolving Termination Date extended to August 17, 2029, with a one-year extension option if Net Liquidity is at least $200.0 million.
Borrowing rates reduced by 0.25%, to SOFR plus 1.75% or base rate plus 0.75%.
Commitment fee is 0.25% per annum on unused commitments when average usage is $50.0 million or less, and 0.20% when usage is above $50.0 million.
IDEX Corporation disclosed that director L. Paris Watts-Stanfield resigned from its Board effective immediately on August 13, 2026. The company said the resignation was not due to any disagreement over its operations, policies or practices. The board size was reduced from ten to nine directors as a result.
Director L. Paris Watts-Stanfield resigned from the Board effective immediately, with the decision dated August 13, 2026.
The company stated the resignation was not due to any disagreement on operations, policies or practices.
Board size was reduced from ten to nine directors.
On August 17, 2026, Advanced Micro Devices closed a $4.75 billion public offering of senior notes in four tranches maturing 2029 through 2036, with coupons from 4.600% to 5.500%. The company intends to use the net proceeds for general corporate purposes, which may include debt repayment, so the filing adds fixed-rate debt obligations for shareholders to weigh.
Four tranches: $1.25 billion 4.600% notes due August 17, 2029; $1.50 billion 5.000% notes due 2031; $1.00 billion 5.250% notes due 2033; $1.00 billion 5.500% notes due 2036
Underwriting agreement dated August 13, 2026 with Barclays, BofA Securities, Citigroup, J.P. Morgan, Morgan Stanley and Wells Fargo, at prices of 99.757% to 99.921% of principal
Notes are general unsecured senior obligations; holders may require repurchase at 101% of principal upon a Change of Control Triggering Event
20/20 BioLabs reported second-quarter 2026 revenue of $0.7 million, up 36.5% from the prior year, and gross margin of 41.7%, up from 30.5%. Net loss widened to $1.5 million from $0.8 million, which the filing attributes partly to one-time Nasdaq listing costs and about $0.7 million in non-cash charges, and the company ended the quarter with $4.5 million in cash and no convertible note debt.
Q2 2026 revenue was $0.7 million, up 36.5% from $0.5 million; OneTest revenue rose 47.1% to $0.7 million.
Gross margin was 41.7% in Q2 2026, compared with 30.5% a year earlier.
Operating expenses rose to $1.5 million from $1.0 million, mainly from Nasdaq direct listing costs and product development.
Net loss was $1.5 million, versus $0.8 million, and cash and cash equivalents were $4.5 million as of June 30, 2026.
ENDRA reported net income of $159,944 for the quarter ended June 30, 2026, compared with a net loss of $1,225,912 a year earlier. The result came from $1.6 million in other income, mainly digital asset gains, while total operating expenses rose to $1.5 million from $1.3 million. The company is pursuing a merger with Noble Africa LLC, which is expected to close in the fourth quarter of 2026 and would rename ENDRA Noble Africa Inc.
Q2 2026 net income was $159,944, versus a net loss of $1,225,912 in Q2 2025.
Total operating expenses were $1,483,256, up from $1,301,090; other income was $1.6 million, mainly from digital asset gains.
As of June 30, 2026, cash was $1,739,943 and restricted cash was $3,800,003.
Merger agreement with Noble Africa dated June 25, 2026; closing expected in Q4 2026, subject to stockholder and regulatory approvals.
Ardelyx disclosed that Chief Commercial Officer Eric Foster notified the company on August 11, 2026, of his decision to resign, effective August 28, 2026. The filing says he is leaving to pursue a new opportunity with a pre-commercial company and that the resignation is not the result of any disagreement with the company. The filing does not name a successor or describe transition arrangements.
Eric Foster gave notice of resignation on August 11, 2026; the resignation is effective August 28, 2026.
Foster is leaving to pursue a new opportunity with a pre-commercial company.
The filing states the resignation is not the result of any disagreement with the company.
InTest Corporation and M&T Bank signed an Eighth Amendment to the company's credit agreement on August 14, 2026. The amendment extends the period during which InTest may request advances under its term loan facility until August 28, 2028. The filing does not disclose any change in loan amount, interest rate, or other economic terms.
Eighth Amendment to the Amended and Restated Loan and Security Agreement dated August 14, 2026
Term loan advance request period extended to August 28, 2028
Agreement is with M&T Bank and covers several InTest subsidiaries, including Ambrell Corporation and Temptronic Corporation
Wendy's said its President, U.S., Pete Suerken, will leave the company effective August 31, 2026, to become President and CEO of Quality Supply Chain Co-op, the system's purchasing cooperative. The company is eliminating his role and creating a Chief Operations Officer position, which it is currently recruiting for, as part of restructuring efforts disclosed on its June quarter earnings call.
Pete Suerken notified Wendy's of his resignation on August 14, 2026; departure anticipated effective August 31, 2026.
The President, U.S. position will be eliminated and a new Chief Operations Officer role created, reporting to the CEO; the company is currently recruiting for it.
Suerken's make-whole RSU award granted July 2025 will vest on a pro-rated basis, and he will receive a pro-rated 2026 annual cash incentive based on actual company performance.
Suerken's other outstanding equity awards will be forfeited.
AvalonBay Communities and Equity Residential completed their merger, forming Vivmark Residential, which the filing says is expected to begin trading on the NYSE as VMRK on August 18, 2026. The combined company issued approximately 400 million common shares, and its board was reconstituted to 14 trustees, seven from each former company. The filing states that Vivmark has not issued guidance for the combined company, so shareholders have no new company-level earnings outlook from this filing.
Each AvalonBay common share converted into 2.793 Vivmark common shares at the Effective Time.
Former AvalonBay stockholders will own approximately 51% and Equity Residential shareholders approximately 49% of the combined company, fully diluted.
Stephen E. Sterrett was appointed Chairman; Tahsinul Zia Huque, Mark J. Parrell and Mark S. Shapiro resigned from the Board.
Vivmark expects an initial annualized dividend of $2.81 per share, according to the press release attached to the filing.
Lexaria Bioscience Corp. received a letter from Nasdaq on August 17, 2026 confirming that it has regained compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2). As a result, the previously requested hearing was cancelled and the company's common stock will continue to be listed and trade on The Nasdaq Capital Market, which removes the near-term risk of delisting for shareholders.
Nasdaq letter dated August 17, 2026 confirmed compliance with the bid price requirement in Listing Rule 5550(a)(2)
Previously requested hearing has been cancelled
Common stock will continue to be listed and trading on The Nasdaq Capital Market
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.